MIR3198-1

Across TCGA pan-cancer cohorts, MIR3198-1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR3198-1 data layer.

The strongest signal is observed in thymoma (THYM), where higher MIR3198-1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3198-1 expression acts as an unfavorable survival marker, although some lineages such as READ and BLCA show a favorable association.

THYM, ACC, and READ are the cancer types where MIR3198-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	III,IV	0.363	0.913	.002	33	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	27	view →
READ	OS	Tertile	II,III,IV	0.935	0.517	.025	20	view →
BLCA	DFS	Tertile	All	0.423	0.310	.026	18	view →
ESCA	DFS	Quartile	III,IV	0.257	0.534	.019	9	view →
SKCM	DFS	Tertile	III,IV	0.369	0.627	.005	9	view →
PCPG	OS	Tertile	All	0.925	1.000	.017	9	view →
UCS	OS	Tertile	All	0.829	0.601	.031	8	view →
COAD	OS	Tertile	II,III,IV	0.690	0.556	.028	7	view →
BRCA	DFS	Tertile	III,IV	0.704	0.814	.032	6	view →
THCA	DFS	Tertile	II,III,IV	0.782	0.887	.039	3	view →
LIHC	OS	Tertile	II,III,IV	1.000	0.403	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR3198-1–THYM (DFS)

Open the THYM breakdown →